NF2 and meningioma: Based on these findings, cIMPACT‐NOW update 833 proposed that meningioma with 1p deletion combined with 22q loss and/or NF2 oncogenic variants should be graded at least CNS WHO grade 2, even in histologically otherwise benign tumours.